Literature DB >> 10525028

Concentration of nitric oxide products in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity.

J R Vyas1, A E Currie, D E Shuker, D J Field, S Kotecha.   

Abstract

AIMS: To determine if nitric oxide (NO) products (nitrate and nitrite) are increased in bronchoalveolar lavage (BAL) fluid obtained from infants who develop chronic lung disease of prematurity (CLD).
METHODS: One hundred and thirty six serial bronchoalveolar lavages were performed on 37 ventilated infants (12 with CLD, 18 with respiratory distress syndrome (RDS), and seven control infants) who did not receive inhaled NO.
RESULTS: During the first week of life nitrate concentration was between 25-31 micromol/l in all three groups. Thereafter, the concentration of BAL fluid nitrate decreased to 14 micromol/l and 5.5 micromol/l, respectively in the RDS and control groups by 14 days of age. In contrast, nitrate in the CLD infants remained constant until 28 days of age (31.3 micromol/l at day 14; p<0.05). In all BAL fluid samples the mean concentration of nitrite was <1.2 micromol/l throughout the first 28 days with no significant differences noted among the three groups.
CONCLUSION: The similar concentration of BAL fluid nitrate in all groups during the first week of life suggest that NO may be important in the adaptation of the pulmonary circulation after birth. However, persistence of nitrate in the BAL fluid of infants with CLD during the second week may reflect pulmonary maladaptation, or, more likely, persisting pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525028      PMCID: PMC1721017          DOI: 10.1136/fn.81.3.f217

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  38 in total

Review 1.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine.

Authors:  A G Dalgleish; B J Thomson; T C Chanh; M Malkovsky; R C Kennedy
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

4.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

Review 5.  The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  R A deLemos; J J Coalson
Journal:  Clin Perinatol       Date:  1992-09       Impact factor: 3.430

Review 6.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

Review 7.  Biochemistry of nitric oxide and its redox-activated forms.

Authors:  J S Stamler; D J Singel; J Loscalzo
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Endothelium-dependent relaxations of piglet pulmonary arteries augment with maturation.

Authors:  T M Zellers; P M Vanhoutte
Journal:  Pediatr Res       Date:  1991-08       Impact factor: 3.756

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys.

Authors:  J C Jackson; E Y Chi; C B Wilson; W E Truog; E C Teh; W A Hodson
Journal:  Am Rev Respir Dis       Date:  1987-04
View more
  3 in total

Review 1.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Exhaled nitric oxide levels in infants with chronic lung disease.

Authors:  Jaana A Leipälä; Olivia Williams; Sanya Sreekumar; Paul Cheeseman; Gerrard F Rafferty; Simon Hannam; Anthony Milner; Anne Greenough
Journal:  Eur J Pediatr       Date:  2004-06-17       Impact factor: 3.183

3.  Inflammatory and oxidative stress airway markers in premature newborns of hypertensive mothers.

Authors:  R J Madoglio; L M S S Rugolo; C S Kurokawa; M P A Sá; J C Lyra; L C O Antunes
Journal:  Braz J Med Biol Res       Date:  2016-08-01       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.